Heparin proteoglycan mimetics (Aplagon)

N/A

Report date: 2026/03/13 20:02:36
NME

Base Information

Drug NameHeparin proteoglycan mimetics (Aplagon)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCoagulation factor inhibitors
TargetsCoagulation factor
Therapy Area/IndicationsIschemiaThrombosisArterial Occlusive Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFinlandIndia
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAplagon Oy
China Registration ClassN/A

Develop Information

Active CompaniesAplagon OyCadila Pharmaceuticals Ltd
Inactive CompaniesN/A
Active IndicationsIschemiaThrombosisArterial Occlusive Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A